Fidelity Investments’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $353K | Sell |
131,865
-4,551
| -3% | -$12.2K | ﹤0.01% | 3103 |
|
|
2025
Q1 | $192K | Buy |
136,416
+9,397
| +7% | +$13.3K | ﹤0.01% | 3264 |
|
|
2024
Q4 | $253K | Buy |
127,019
+73,977
| +139% | +$147K | ﹤0.01% | 3176 |
|
|
2024
Q3 | $167K | Buy |
+53,042
| New | +$167K | ﹤0.01% | 3254 |
|
|
2024
Q1 | – | Sell |
-6
| Closed | -$10 | – | 5338 |
|
|
2023
Q4 | $10 | Sell |
6
-1,309
| -100% | -$2.18K | ﹤0.01% | 5312 |
|
|
2023
Q3 | $1.18K | Sell |
1,315
-67
| -5% | -$60 | ﹤0.01% | 4630 |
|
|
2023
Q2 | $2.97K | Sell |
1,382
-39,062
| -97% | -$84K | ﹤0.01% | 4499 |
|
|
2023
Q1 | $78.9K | Sell |
40,444
-4,613,009
| -99% | -$9M | ﹤0.01% | 3276 |
|
|
2022
Q4 | $17.9M | Sell |
4,653,453
-3,019,684
| -39% | -$11.6M | ﹤0.01% | 1657 |
|
|
2022
Q3 | $37M | Sell |
7,673,137
-7,909
| -0.1% | -$38.1K | ﹤0.01% | 1366 |
|
|
2022
Q2 | $61.1M | Hold |
7,681,046
| – | – | 0.01% | 1174 |
|
|
2022
Q1 | $113M | Buy |
7,681,046
+8,373
| +0.1% | +$123K | 0.01% | 1022 |
|
|
2021
Q4 | $155M | Hold |
7,672,673
| – | – | 0.01% | 901 |
|
|
2021
Q3 | $208M | Hold |
7,672,673
| – | – | 0.02% | 791 |
|
|
2021
Q2 | $187M | Sell |
7,672,673
-88,912
| -1% | -$2.17M | 0.01% | 856 |
|
|
2021
Q1 | $189M | Hold |
7,761,585
| – | – | 0.02% | 812 |
|
|
2020
Q4 | $248M | Buy |
7,761,585
+90,000
| +1% | +$2.88M | 0.02% | 662 |
|
|
2020
Q3 | $253M | Buy |
7,671,585
+2,427,354
| +46% | +$80.1M | 0.03% | 548 |
|
|
2020
Q2 | $245M | Buy |
+5,244,231
| New | +$245M | 0.03% | 525 |
|